Skip to content
The Nexus
DossierENTITY

Harith Rajagopalan

Coverage of Harith Rajagopalan in the Nexus archive.

Earliest in view: May 16 · 12:41 UTCMost recent: May 16 · 12:41 UTC
Co-mentioned in this coverage
GLP-1topic1Type 2 diabetestopic1obesitytopic1
Recent coverage
  • HEALTHMay 16 · 12:41 UTCTHE HILL
    First human GLP-1 gene therapy trial gets green light

    The first human GLP-1 gene therapy trial has received approval. Dr. Harith Rajagopalan commented on the potential of GLP-1 medicines in treating obesity and Type 2 diabetes. This development may lead to new treatments for these conditions.

Harith Rajagopalan · Dossier · The Nexus